Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck (Q34287207)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck |
scientific article |
Statements
1 reference
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck (English)
1 reference
Everett E Vokes
1 reference
Denis Soulieres
1 reference
Neil N Senzer
1 reference
Sanjiv S Agarwala
1 reference
Lillian L Siu
1 reference
1 January 2004
1 reference
1 reference
Identifiers
1 reference